Allianz Biosciences Private Limited, a active private limited company, was established on 17 January 2003 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN2003PTC050203. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹5.50 M.
Formerly known as Healkraft Remedies (India) Private Limited. It upholds a compliant status. Employing 123 professional, Its leadership includes Srinivasan Balamurugan (Director), Murugesan Senthil Kumar (Whole-Time Director). Past directors included Venkata Krishna Murty Ponnapalli, Raghavan Srinivasa Ranganathan, Hiralal Goud. It holds ₹4.80 Cr open charges and ₹1.00 M settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Block No. 14, R.A. Building, Iii Floor, Old No. 19, New No. 72, Marshalls Road,, Egmore,, Chennai, Tamil Nadu, 600008.
U24231TN2003PTC050203
050203
17 January 2003
₹7.00 M
₹5.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Allianz Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasan Balamurugan | Director | 23 Oct 2019 | Current |
| Murugesan Senthil Kumar | Whole-Time Director | 08 Jul 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Oct 2019 | Past |
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
| Pramod Abcsdd | Director | 08 Jul 2009 | Past |
| Pramod Abcsdd | Manager | 25 Jun 2013 | Past |
| Pramod Abcsdd | Additional Director | 26 Dec 2020 | Past |
| Pramod Abcsdd | Director | 01 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Allianz Biosciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.23% increase. The company also saw a substantial improvement in profitability, with a 45.64% increase in profit. The company's net worth moved up by a moderate rise of 0.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Allianz Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹48,000,000.00
₹1,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2011 | Citi Bank N.A. | ₹4.80 Cr | Open |
| 10 Feb 2020 | State Bank Of India | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Allianz Biosciences has a workforce of 123 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Allianz Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allianz Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 10 Feb 2020 via Charge ID 100328743 with State Bank Of India was fully satisfied on 10 Nov 2025. was documented.
Progress on Allianz Biosciences Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.
Progress on Allianz Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.
The activity A charge with Citi Bank N.A. of Rs. 48.00 M registered on 20 Jul 2011 with Charge ID 10303858 was modified on 05 Jun 2023. was completed.
A charge with State Bank Of India amounted to Rs. 1.00 M with Charge ID 100328743 was registered on 10 Feb 2020. was recorded as a recent event.
The activity Srinivasan Balamurugan was appointed as a Director was appointed as a Director on 23 Oct 2019 & has been associated with this company since 6 years 2 months . was completed.
The CIN of Allianz Biosciences Private Limited is U24231TN2003PTC050203.
Allianz Biosciences Private Limited is headquartered at Block No. 14, R.A. Building, Iii Floor, Old No. 19, New No. 72, Marshalls Road,, Egmore,, Chennai, Tamil Nadu, 600008.
Allianz Biosciences Private Limited was incorporated on 17 January 2003.
The current directors of Allianz Biosciences Private Limited are
The primary industry of Allianz Biosciences Private Limited is Manufacturing.
Allianz Biosciences Private Limited is unlisted.
The authorized capital of Allianz Biosciences Private Limited is ₹7.00 M, and the paid-up capital is ₹5.50 M.
The compliance status of Allianz Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX